Delcath Systems, Inc.Delcath Systems, Inc.Delcath Systems, Inc.

Delcath Systems, Inc.

No trades
See on Supercharts
Market capitalization
‪121.59 M‬USD
−2.97USD
‪−47.68 M‬USD
‪2.07 M‬USD
‪21.76 M‬
Beta (1Y)
−0.67

About Delcath Systems, Inc.

CEO
Gerard J. Michel
Headquarters
Queensbury
Employees (FY)
76
Founded
1988
ISIN
US24661P8077
FIGI
BBG000BY2VF5
Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded in August 1988 and is headquartered in Queensbury, NY.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of DCTH is 4.95 USD — it has decreased by 1.00% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Delcath Systems, Inc. stocks are traded under the ticker DCTH.
Delcath Systems, Inc. is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Delcath Systems, Inc. has a max estimate of 22.00 USD and a min estimate of 16.00 USD.
DCTH earnings for the last quarter are −1.14 USD whereas the estimation was −0.52 USD which accounts for −119.23% surprise. Estimated earnings for the next quarter are −0.54 USD. See more details about Delcath Systems, Inc. earnings.
Delcath Systems, Inc. revenue for the last quarter amounts to ‪434.00 K‬ USD despite the estimated figure of ‪682.64 K‬ USD. In the next quarter revenue is expected to reach ‪547.75 K‬ USD.
Yes, you can track Delcath Systems, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, DCTH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Delcath Systems, Inc. stock right from TradingView charts — choose your broker and connect to your account.
DCTH reached its all-time high on Apr 29, 2010 with the price of 515872000000.00 USD, and its all-time low was 2.25 USD and was reached on Nov 14, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 14, 2024, the company has 76.00 employees. See our rating of the largest employees — is Delcath Systems, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Delcath Systems, Inc. EBITDA is ‪−37.79 M‬ USD, and current EBITDA margin is ‪−1.84 K‬%. See more stats in Delcath Systems, Inc. financial statements.